FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/17/2023
Back to search
Official data from USPTO
VISISURE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
10/17/2023
Trademark type
Combined
Nice classes
5, 10
Filing date
06/02/2022
Registration date
06/20/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/20/2023
Last transaction
06/20/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
25
Owner location
CH
Examiner
HSU, FONG
Law office
O20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word VISISURE to the right of a stylized check mark design comprised of a block outline of the letter "V".
Holders and representatives
Holders
NOVARTIS AG
Representatives
Maury M. Tepper, III Tepper & Eyster, PLLC
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Class 10
Drug delivery devicesnamely medical injection devices sold empty for administration of pharmaceutical preparations
Publications
History of USPTO decisions and trademark events.
29 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/26/2023
FIMP
FINAL DISPOSITION PROCESSED
09/26/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/20/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/20/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
06/20/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/04/2023
PUBO
PUBLISHED FOR OPPOSITION
04/04/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/15/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/27/2023
RFNT
REFUSAL PROCESSED BY IB
02/15/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/02/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/02/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/02/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/25/2023
RFRR
REFUSAL PROCESSED BY MPU
01/25/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/13/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/13/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
12/13/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/13/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/13/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/13/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/24/2022
CNRT
NON-FINAL ACTION WRITTEN
11/23/2022
MAFR
APPLICATION FILING RECEIPT MAILED
11/08/2022
DOCK
ASSIGNED TO EXAMINER
11/07/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/04/2022
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
11/02/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/27/2022
Continuous trademark protection
Get notified about every new filing that threatens VISISURE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.